Literature DB >> 10761995

The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): clinical-pathological characterization.

C Fleury1, F Bérard, B Balme, L Thomas.   

Abstract

The clinical and pathological characteristics of cutaneous melanomas occurring in Camargue-type gray-skinned horses are reported. Examination of 83 tumor-bearing horses revealed that the tumors occurred most frequently underneath the tail (93.9%) and at high rates in the peri-anal region (43.0%), the lips (33.0%), and the eyelids (24.0%), but rarely in the vulva (3.8%). Tumorous lesions were characterized by the presence of either hemispheric nodules or large infiltrated plaques, or their combinations. Microscopic examination indicated that tumorous lesions were composed mostly of melanocytes and numerous melanophages and that component cells manifested a remarkable cellular atypia with anisocytosis and anisokarinosis. Pathological examination of lesions corresponding to earlier stages of the tumors disclosed that tumor formation and its related melanogenesis occurred in close topographical association with apocrine sweat glands, but not at the dermal-epidermal junction. Larger nodules of the tumors were often composed of a concentric deposition of cell layers, each being separated by dermal components from the epidermis. Because of the absence of their tropism toward the epidermis and their multiloculation, horse melanomas are considered to be different in their pathological characteristics from human melanomas.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10761995     DOI: 10.1034/j.1600-0749.2000.130108.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  8 in total

1.  Recent advances in sunlight-induced carcinogenesis using the Xiphophorus melanoma model.

Authors:  André A Fernandez; Lakshmi Paniker; Rachel Garcia; David L Mitchell
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-03-30       Impact factor: 3.228

2.  Establishment and characterization of a primary and a metastatic melanoma cell line from Grey horses.

Authors:  Monika H Seltenhammer; Elisabeth Sundström; Claudia Meisslitzer-Ruppitsch; Petra Cejka; Jedrzej Kosiuk; Josef Neumüller; Marlene Almeder; Otto Majdic; Peter Steinberger; Udo M Losert; Johannes Stöckl; Leif Andersson; Johann Sölkner; Monika Vetterlein; Anna Golovko
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-08-28       Impact factor: 2.416

3.  Faecal Proteomics and Functional Analysis of Equine Melanocytic Neoplasm in Grey Horses.

Authors:  Parichart Tesena; Amornthep Kingkaw; Narumon Phaonakrop; Sittiruk Roytrakul; Paviga Limudomporn; Wanwipa Vongsangnak; Attawit Kovitvadhi
Journal:  Vet Sci       Date:  2022-02-21

4.  Malignant melanoma in a grey horse: case presentation and review of equine melanoma treatment options.

Authors:  Lucy Va Metcalfe; Peter J O'Brien; Stratos Papakonstantinou; Stephen D Cahalan; Hester McAllister; Vivienne E Duggan
Journal:  Ir Vet J       Date:  2013-11-06       Impact factor: 2.146

Review 5.  Modeling Melanoma In Vitro and In Vivo.

Authors:  Kimberley A Beaumont; Nethia Mohana-Kumaran; Nikolas K Haass
Journal:  Healthcare (Basel)       Date:  2013-12-23

Review 6.  Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.

Authors:  Vratislav Horak; Anna Palanova; Jana Cizkova; Veronika Miltrova; Petr Vodicka; Helena Kupcova Skalnikova
Journal:  Genes (Basel)       Date:  2019-11-09       Impact factor: 4.096

7.  In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.

Authors:  Lisa Annabel Weber; Anne Funtan; Reinhard Paschke; Julien Delarocque; Jutta Kalbitz; Jessica Meißner; Karsten Feige; Manfred Kietzmann; Jessika-Maximiliane V Cavalleri
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

Review 8.  Spontaneously occurring melanoma in animals and their relevance to human melanoma.

Authors:  Louise van der Weyden; Thomas Brenn; E Elizabeth Patton; Geoffrey A Wood; David J Adams
Journal:  J Pathol       Date:  2020-07-31       Impact factor: 7.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.